FAF could be a useful tool for SC and SLC

Article

Fundus autofluorescence (FAF) imaging could be a useful tool for assessing patients with serpiginous choroidopathy (SC) and serpiginous-like choroidopathy (SLC).

Fundus autofluorescence (FAF) imaging could be a useful tool for assessing patients with serpiginous choroidopathy (SC) and serpiginous-like choroidopathy (SLC), according to a paper published in the journal Eye.

Dr E. Carreno et al., Department of Ophthalmology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain, conducted a prospective case series on 12 patients with SC and SLC. All patients experienced FAF imaging from July 2009 to December 2010.

There was bilateral involvement in nine cases and three different FAF imaging patterns were revealed. This included active inflammation, transitional and inactive inflammation.

FAF can be a helpful tool for imaging SC and SLC patients and it may be possible to reserve other invasive technique. For example FA could be used for patients with suspicious activity disclosed by FAF imaging.

The abstract can be found here.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.